A multi-center, open-label, uncontrolled, single-arm, extension study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease

• Protocol code: ID-069A302
• EudraCT code: 2018-002210-12
• Research group: Neurodegenerative Diseases
• Service: Internal Medicine
• Principal investigator:  Camprodon Gomez, Maria
• Pathology: Malalties del sistema nerviós
• Phase: Fase III
• Status: Recruiting volunteers